Ingenza has partnered with Oxford-based biotech company HydRegen to develop a more sustainable and cost-effective method for manufacturing amine-based chemicals, eliminating the need for heavy metal catalysts. The company turned to Ingenza to help improve the expression levels of a new candidate biocatalyst,…
Ingenza – a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator – is delighted to announce its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group. Following a detailed strategic review, the company has embarked on…
Enzyme evolution can be used to take a wild-type enzyme that is in some way unsuitable for a bioprocess of interest and create a strain with enhanced capabilities. This iterative process is based on the design-build-test-learn (DBTL) cycle,1 and can be used…
Industrial biotech specialist Ingenza is delighted to announce that it is collaborating with Cellugy to accelerate the development of its innovative platform for producing biofabricated cellulose. This technology will provide a sustainable alternative to fossil-based petrochemicals in various industrial applications, starting with personal care…
Scottish CRDMO Ingenza has secured innovation funding to adapt its codABLE™ machine learning platform to precisely control recombinant protein expression in the industrial yeast Pichia pastoris. This game-changing project will accelerate the development of therapeutics, enzymes and other proteins by harnessing machine learning to…
Edinburgh, Scotland – Ingenza, a dynamic CDMO and leader in engineering biology, is pleased to announce its strategic partnership with Opvia, a Quality Management Systems (QMS) provider. This partnership is driven by Ingenza’s commitment to enhance and centralise its quality…
Ingenza is proud to announce that our molecular biology team recently co-authored a groundbreaking research paper published in Applied Microbiology International. The study addressed current challenges in producing recombinant proteins in the methylotrophic yeast Pichia pastoris. P. pastoris is a…
Ingenza’s novel ester-impregnated pH strips significantly improve the accuracy of locating nasogastric (NG) feeding tubes in a study carried out in 10 NHS hospitals, as published in Diagnostic and Prognostic Research. The peer-reviewed paper found the innovative test to be…
The fast-moving pace of the biopharmaceutical sector and the diversity of potential therapeutic targets are putting the industry’s resources under ever-growing pressure. Each new cell line or manufacturing technology requires dedicated time, space and staff – not to mention in-house…
Ingenza and Phibro Ethanol – a division of Phibro Animal Health Corporation – have joined forces to engineer a novel yeast strain that will increase yield in the commercial production of bioethanol under both challenging and conventional environmental conditions, further driving the switch to clean biofuels. This latest innovation –…